This list is based on the watchlists of people on Stock Events who follow ISOFOL-TO1.ST. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Isofol Medical AB (publ) operates as a clinical stage biotech company. The company develops arfolitixorin, which is in phase Ib/II clinical trial for the treatment of metastatic colorectal cancer. Isofol Medical AB (publ) was incorporated in 2008 and is based in Gothenburg, Sweden.
The current price of ISOFOL-TO1.ST is SEK0.14 SEK — it has increased by +0.75% in the past 24 hours. Watch Isofol Medical AB stock price performance more closely on the chart.
What is Isofol Medical AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Isofol Medical AB stocks are traded under the ticker ISOFOL-TO1.ST.
What is Isofol Medical AB market cap?▼
Today Isofol Medical AB has the market capitalization of 37.95M
When is the next Isofol Medical AB earnings date?▼
Isofol Medical AB is going to release the next earnings report on May 19, 2026.
What is Isofol Medical AB revenue for the last year?▼
Isofol Medical AB revenue for the last year amounts to 0 SEK.
What is Isofol Medical AB net income for the last year?▼
ISOFOL-TO1.ST net income for the last year is -149.73M SEK.
How many employees does Isofol Medical AB have?▼
As of April 03, 2026, the company has 6 employees.
In which sector is Isofol Medical AB located?▼
Isofol Medical AB operates in the Health Care sector.
When did Isofol Medical AB complete a stock split?▼
Isofol Medical AB has not had any recent stock splits.
Where is Isofol Medical AB headquartered?▼
Isofol Medical AB is headquartered in Gothenburg, DE.